T2 Biosystms Price To Sales Ratio Over Time
| TTOO Stock | USD 0.52 0.01 1.96% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out T2 Biosystms Performance and T2 Biosystms Correlation. TTOO |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.999 | Quarterly Revenue Growth (0.01) | Return On Assets (0.90) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare T2 Biosystms and related stocks such as Biocept, Genetic Technologies, and HTG Molecular Diagnostics Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GENE | 49.2 K | 466 | 1.3 K | 4.0408 | 13.3306 | 35.1535 | 25.5453 | 115 | 693 | 23.6934 | 542 | 3.89 | 1.8723 | 1.3972 | 1.33 |
| INBS | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 207 | 26.672 | 26.672 | 0.9367 | 0.89 |
| BIAF | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 1.5 K | 5.0775 | 4.82 |
| TMO | 1.3833 | 1.4604 | 1.8548 | 3.0648 | 2.9539 | 3.3336 | 3.0484 | 3.5856 | 3.6934 | 5.0876 | 5.725 | 6.7046 | 4.8062 | 4.7807 | 5.02 |
| ILMN | 7.4831 | 3.4628 | 7.6265 | 7.6265 | 7.6265 | 7.6265 | 7.6265 | 11.2651 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | 4.747 | 4.51 |
| DHR | 0.1775 | 1.328 | 1.4259 | 1.888 | 2.0304 | 2.1184 | 2.825 | 3.1234 | 3.2193 | 5.4306 | 6.2403 | 7.0756 | 5.4207 | 7.1319 | 7.49 |
| WAT | 1.4349 | 3.6334 | 4.1509 | 4.4861 | 4.7799 | 5.4256 | 5.0091 | 6.6759 | 6.0021 | 6.5657 | 6.4951 | 8.2354 | 6.9145 | 6.5788 | 4.02 |
| IDXX | 3.6475 | 3.5863 | 3.9453 | 4.1062 | 4.9942 | 4.2153 | 5.927 | 6.9705 | 7.3008 | 9.3428 | 15.7611 | 17.4477 | 10.1311 | 12.5939 | 13.22 |
| ISPC | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5246 | 1.5571 | 0.8179 | 5.732 | 1.1675 | 9.1158 | 9.57 |
T2 Biosystms and related stocks such as Biocept, Genetic Technologies, and HTG Molecular Diagnostics Price To Sales Ratio description
Price to Sales Ratio is figured by comparing T2 Biosystms stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on T2 Biosystms sales, a figure that is much harder to manipulate than other T2 Biosystms multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
Check out T2 Biosystms Performance and T2 Biosystms Correlation. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
T2 Biosystms technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.